| 标题 |
Axitinib versus sorafenib as a second-line therapy in Asian patients with metastatic renal cell carcinoma: results from a randomized registrational study |
| 网址 | |
| DOI | |
| 其它 |
期刊:OncoTargets and therapy 作者:Qin S; Bi F; Jin J; Cheng Y; Guo J; et al 出版日期:2015/06/08 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)